These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31573846)

  • 1. The antagonist of CXCR1 and CXCR2 protects
    Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
    Li F; Zhang X; Gordon JR
    Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
    Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
    Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy.
    Ye Y; Zhang Y; Wang B; Walana W; Wei J; Gordon JR; Li F
    Biomed Pharmacother; 2018 Nov; 107():1142-1150. PubMed ID: 30257327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine CXCR1/2 antagonist CXCL8
    Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
    Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
    Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
    Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
    Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
    Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
    J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose-Induced Mesangial Injury.
    Cui S; Zhu Y; Du J; Khan MN; Wang B; Wei J; Cheng JW; Gordon JR; Mu Y; Li F
    Endocrinology; 2017 Jun; 158(6):1671-1684. PubMed ID: 28387853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined CXCR1/CXCR2 antagonism decreases radiation-induced alveolitis in the mouse.
    Fox J; Gordon JR; Haston CK
    Radiat Res; 2011 May; 175(5):657-64. PubMed ID: 21342009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice.
    Schneberger D; Gordon JR; DeVasure JM; Boten JA; Heires AJ; Romberger DJ; Wyatt TA
    Pulm Pharmacol Ther; 2015 Apr; 31():55-62. PubMed ID: 25681618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.
    Walana W; Ye Y; Li M; Wang J; Wang B; Cheng JW; Gordon JR; Li F
    Biomed Pharmacother; 2018 Jul; 103():253-261. PubMed ID: 29655167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
    Russo RC; Garcia CC; Teixeira MM; Amaral FA
    Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.
    Bertini R; Barcelos LS; Beccari AR; Cavalieri B; Moriconi A; Bizzarri C; Di Benedetto P; Di Giacinto C; Gloaguen I; Galliera E; Corsi MM; Russo RC; Andrade SP; Cesta MC; Nano G; Aramini A; Cutrin JC; Locati M; Allegretti M; Teixeira MM
    Br J Pharmacol; 2012 Jan; 165(2):436-54. PubMed ID: 21718305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes.
    Walana W; Wang JJ; Yabasin IB; Ntim M; Kampo S; Al-Azab M; Elkhider A; Dogkotenge Kuugbee E; Cheng JW; Gordon JR; Li F
    Hum Immunol; 2018 Nov; 79(11):809-816. PubMed ID: 30125599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
    Zaslaver A; Feniger-Barish R; Ben-Baruch A
    J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.